Journal article

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Brunner, T., Geiger, M., Grabenbauer, G., Mantoni, T., Cavallaro, A., Sauer, R., Hohenberger, W., & Mckenna, W. (2008). A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 26(15).

MLA Style

Brunner, T, et al. “A Phase I-Trial of the HIV Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 26, no. 15, 2008.

Chicago Style

Brunner, T, M Geiger, G Grabenbauer, et al. 2008. “A Phase I-Trial of the HIV Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer.” JOURNAL OF CLINICAL ONCOLOGY 26 (15).
Print

Authors

+ Brunner, T More by this author

Role:: Author

+ Geiger, M More by this author

Role:: Author

+ Grabenbauer, G More by this author

Role:: Author

+ Mantoni, T More by this author

Role:: Author

+ Cavallaro, A More by this author

Role:: Author

More authors...

Journal:: JOURNAL OF CLINICAL ONCOLOGY More from this journal
Volume:: 26
Issue:: 15
Publication date:: 2008-05-20
ISSN:: 0732-183X

Pubs id:: pubs:356120
UUID:: uuid:15fdd538-e277-4660-95a0-7085e699b4f5
Local pid:: pubs:356120
Source identifiers:: 356120
Deposit date:: 2013-11-17
ARK identifier:: ark:/29072/ora_15fdd538e277466095a07085e699b4f5

Terms of use

Copyright date:: 2008

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP